Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Silke Zinke"'
Autor:
Andreas Reich, Anja Weiß, Lisa Lindner, Xenofon Baraliakos, Denis Poddubnyy, Silke Zinke, Carsten Stille, Anja Strangfeld, Anne C. Regierer
Publikováno v:
Arthritis Research & Therapy, Vol 26, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/432a9caedae541eca13d243ff46b9f09
Autor:
Andreas Reich, Anja Weiß, Lisa Lindner, Xenofon Baraliakos, Denis Poddubnyy, Silke Zinke, Carsten Stille, Anja Strangfeld, Anne C. Regierer
Publikováno v:
Arthritis Research & Therapy, Vol 25, Iss 1, Pp 1-12 (2023)
Abstract Background In patients with axial spondyloarthritis (axSpA) or psoriatic arthritis (PsA), concomitant depression might have a negative impact on the course of disease and treatment outcomes. The aims of this analysis are to determine the pre
Externí odkaz:
https://doaj.org/article/796b5a293d6f487399a75141e23ac60a
Autor:
Katinka Albrecht, Hans-Peter Tony, Anja Strangfeld, Joern Kekow, Martin Schäfer, Yvette Meissner, Silke Zinke
Publikováno v:
RMD Open, Vol 9, Iss 4 (2023)
Objective To estimate the effects of Janus kinase inhibitors (JAKi), tumour necrosis factor inhibitors (TNFi), other biologic(b) or conventional synthetic(cs) disease-modifying antirheumatic drugs (DMARDs) on the risk of major adverse cardiovascular
Externí odkaz:
https://doaj.org/article/a12b1332d02044629ece91e4965e6012
Autor:
Denis Poddubnyy, Hildrun Haibel, Fabian Proft, Mikhail Protopopov, Valeria Rios Rodriguez, Murat Torgutalp, Judith Rademacher, Silke Zinke, Henning Christian Brandt, Kirsten Karberg, Burkhard Muche, Gerd Rüdiger Burmester, Maryna Verba, Susanne Lüders, Julia Schally, Jan Brandt-Juergens, Henriette Käding
Publikováno v:
RMD Open, Vol 8, Iss 2 (2022)
Objectives This study aimed to evaluate the Disease Activity index for PSoriatic Arthritis (DAPSA) based on a quick quantitative C reactive protein (qCRP) assay (Q-DAPSA) in a multicentre, prospective, cross-sectional study in patients with psoriatic
Externí odkaz:
https://doaj.org/article/b7907cf5e1d241d9840bc807cc0b0d4c
Autor:
Julia Schally, Henning Christian Brandt, Jan Brandt-Jürgens, Gerd R. Burmester, Hildrun Haibel, Henriette Käding, Kirsten Karberg, Susanne Lüders, Burkhard Muche, Mikhail Protopopov, Valeria Rios Rodriguez, Murat Torgutalp, Maryna Verba, Silke Zinke, Denis Poddubnyy, Fabian Proft
Publikováno v:
Therapeutic Advances in Musculoskeletal Disease, Vol 14 (2022)
Objectives: The Simplified Disease Activity Index (SDAI) is a recommended composite score for assessing the remission status in patients with rheumatoid arthritis (RA). However, determination of C-reactive protein (CRP) levels takes several hours and
Externí odkaz:
https://doaj.org/article/681470355ead4df098ebf1e88cf5929e
Autor:
Fabian Proft, Julia Schally, Henning Christian Brandt, Jan Brandt-Juergens, Gerd Rüdiger Burmester, Hildrun Haibel, Henriette Käding, Kirsten Karberg, Susanne Lüders, Burkhard Muche, Mikhail Protopopov, Judith Rademacher, Valeria Rios Rodriguez, Murat Torgutalp, Maryna Verba, Silke Zinke, Denis Poddubnyy
Publikováno v:
Therapeutic Advances in Musculoskeletal Disease, Vol 14 (2022)
Objectives: The objective of the study was to validate the Ankylosing Spondylitis Disease Activity Score (ASDAS) based on a quick quantitative C-reactive protein (qCRP) assay (ASDAS-Q) in a multicentre, prospective, cross-sectional study in patients
Externí odkaz:
https://doaj.org/article/abe150b2f45c4be5b7b2cbae2c99d174
Publikováno v:
RMD Open, Vol 6, Iss 3 (2020)
Externí odkaz:
https://doaj.org/article/4266e92b3a2a4c7e831657718693e0b2
Publikováno v:
Zeitschrift für Rheumatologie. 81:463-471
Autor:
Hanns-Martin Lorenz, Sonja Froschauer, Regina Hanke, Bernhard Hellmich, Andreas Krause, Heinz-Jürgen Lakomek, Ina Kötter, Johannes Strunk, Anna Voormann, Silke Zinke
Publikováno v:
Zeitschrift für Rheumatologie. 81:487-491
Autor:
Christoph Fiehn, Silke Zinke, Jennifer S. Haas, Dominic Meise, Julia Theil, Margot Gurrath, Hans-Dieter Orzechowski
Publikováno v:
Zeitschrift für Rheumatologie.
Objective To investigate treatment patterns in patients with rheumatoid arthritis (RA) in Germany who had previously received conventional synthetic (cs) or biologic (b) disease-modifying antirheumatic drugs (DMARDs). Methods Patients with RA who ini